Blanket Purchase Agreement W81XWH17A0008

The Department of Justice Drug Enforcement Administration awarded a single-award blanket purchase agreement to Government Scientific Source Inc. with a potential value of $1,250,000.00 and a period of performance from September 2021 through September 2026. Under the terms of the agreement and an initial BPA call valued at $249,000, Government Scientific Source Inc. will perform synthesis of chemical substances for diversion and control purposes at its facility in Herndon, Virginia through...

The Naval Medical Logistics Command awarded an indefinite-delivery contract to Siemens Healthcare Diagnostics Inc. to supply cannabinoid immunoassay reagent kits in support of the Department of Defense Drug Demand Reduction Program. The contract has a five-year ordering period from June 2021 through June 2026 with an estimated value of $750,270. Task orders issued against the contract by various military medical agencies require Siemens to provide the immunoassay kits used to detect cannabinoids...

The Drug Enforcement Administration (DEA), a civilian federal agency, has awarded a single-award Blanket Purchase Agreement (BPA) valued up to $1,803,619.58 to the University of Arkansas for Medical Sciences (UAMS) to conduct a dose response study on up to 16 hallucinogenic test substances. The purpose of this contract is to evaluate the abuse potential of these substances and determine whether they should be controlled under the Controlled Substances Act. UAMS, a large academic medical...

The Drug Enforcement Administration (DEA) awarded a $1,031,685.80 Blanket Purchase Agreement (BPA) to the University of North Texas Health Science Center at Fort Worth (UNTHSC), a U.S. state government entity and educational institution, to conduct investigational studies and provide methodology for evaluating the abuse potential of synthetic opioids and other depressant drugs. This 5-year single-award IDV contract, with no set-aside, is managed by the DEA's Diversion Control Division and is...

The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...

The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the preparation and distribution of research drug products. The $19,975,000 contract has a period of performance from March 20, 2025 to March 19, 2029, with a final completion date of March 19, 2026 for the initial $1,497,865 delivery order. RTI International, an experienced...

The federal contract IDV award to Cayman Chemical Co Inc. is a $5,000,000 multiple-award indefinite delivery contract with the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract, awarded on September 30, 2019, is for the provision of DLS Traceable Opioid Kits to support the CDC's substance abuse prevention and drug enforcement initiatives. Under this IDV, Cayman Chemical has received multiple firm fixed-price delivery orders totaling over $5.4 million for the supply...

The federal contract IDV awarded to Specgx LLC, doing business as Mallinckrodt Pharmaceuticals, is a single-award Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,154,058.30 over five years, establishes Specgx LLC as the national supply source for Methylphenidate HCL Extended-Release Tablets in 10mg and 20mg strengths for the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs....

The National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to Alchem Laboratories Corporation. The contract has a potential value of $7,777,665 and a period of performance from September 2017 to September 2022. Under the contract, Alchem Laboratories Corporation provides non-good manufacturing practices synthesis of small molecules to support the National Cancer Institute's...

The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports NCATS'...